Peel Hunt Reaffirms “Buy” Rating for Kier Group (LON:KIE)

Share on StockTwits

Kier Group (LON:KIE)‘s stock had its “buy” rating reiterated by equities researchers at Peel Hunt in a research report issued to clients and investors on Thursday, September 20th.

Several other brokerages have also recently weighed in on KIE. Liberum Capital restated a “buy” rating on shares of Kier Group in a report on Friday, September 14th. Barclays initiated coverage on Kier Group in a report on Thursday, June 7th. They set an “underweight” rating on the stock. Finally, Numis Securities restated a “buy” rating on shares of Kier Group in a report on Thursday, June 7th. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of GBX 1,495.80 ($19.55).

Shares of Kier Group stock traded down GBX 5.50 ($0.07) on Thursday, hitting GBX 876 ($11.45). 265,788 shares of the company were exchanged, compared to its average volume of 472,724. Kier Group has a 1-year low of GBX 942 ($12.31) and a 1-year high of GBX 1,505 ($19.67).

About Kier Group

Kier Group plc provides construction services in the United Kingdom, the Middle East, the Far East, and Australia. The company operates in four divisions: Property, Residential, Construction, and Services. It offers construction services, including civil engineering, construction management, design and build, engineering design, mechanical and electrical design, interiors and refurbishments, and construction related technical services, as well as infrastructure support services for rail network.

See Also: Understanding the different types of bonds

Analyst Recommendations for Kier Group (LON:KIE)

Receive News & Ratings for Kier Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kier Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.